KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Free Cash Flow (2016 - 2025)

Medpace Holdings' Free Cash Flow history spans 11 years, with the latest figure at $188.1 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 2.78% year-over-year to $188.1 million; the TTM value through Dec 2025 reached $681.9 million, up 19.15%, while the annual FY2025 figure was $681.9 million, 19.15% up from the prior year.
  • Free Cash Flow reached $188.1 million in Q4 2025 per MEDP's latest filing, down from $235.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $235.5 million in Q3 2025 to a low of $37.0 million in Q1 2022.
  • Average Free Cash Flow over 5 years is $111.9 million, with a median of $104.6 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: plummeted 36.78% in 2021, then skyrocketed 108.58% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $61.8 million in 2021, then skyrocketed by 106.29% to $127.4 million in 2022, then grew by 14.88% to $146.4 million in 2023, then increased by 25.01% to $183.0 million in 2024, then increased by 2.78% to $188.1 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Free Cash Flow are $188.1 million (Q4 2025), $235.5 million (Q3 2025), and $142.4 million (Q2 2025).